Delos Santos, Gertrudes D.
HRN: 21-17-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/10/2024
04/16/2024
IV
500 LD Then 250
Q24
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes